HighMark Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
HighMark Wealth Management's LLY Position: Q2 2026 in Review
HighMark Wealth Management increased its Eli Lilly (LLY) stake by 0.35% in Q2 2026, buying an estimated $6.13K and bringing the position to 1,734 shares worth $2.08M. The position accounts for 0.7% of the portfolio, ranked #25.
HighMark Wealth Management first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- HighMark Wealth Management held 1,734 shares of Eli Lilly worth $2.08M as of Q2 2026.
- HighMark Wealth Management bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
- Eli Lilly made up 0.7% of HighMark Wealth Management's portfolio in Q2 2026, its #25 holding.
- HighMark Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.